Tharimmune, Inc.
THAR
$1.10
-$0.05-4.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.26% | 15.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.47% | 62.86% | |||
| Operating Income | 0.47% | -62.86% | |||
| Income Before Tax | -0.65% | -63.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.65% | -63.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.65% | -63.26% | |||
| EBIT | 0.47% | -62.86% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 12.78% | -1.52% | |||
| Normalized Basic EPS | 12.77% | -1.52% | |||
| EPS Diluted | 12.78% | -1.52% | |||
| Normalized Diluted EPS | 12.77% | -1.52% | |||
| Average Basic Shares Outstanding | 15.39% | 60.83% | |||
| Average Diluted Shares Outstanding | 15.39% | 60.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||